“Changing the world can happen anywhere, and anyone can do it.” These words were spoken by Admiral William H. McRaven, United States Navy four-star admiral who served as the ninth commander of the United States Special Operations Command, during his 2014 commencement speech at the University of Texas at Austin…

The greatest global public health crisis in a century has put the life sciences industry in the spotlight. Called to center stage, the entire industry delivered on innovation and responsiveness. …

While we are no means out of the woods, the FDA’s analysis this week of Johnson & Johnson’s COVID-19 single-dose vaccine is more good news that points to the gradual return to normal life. Throughout the crisis, the health care industry’s response to COVID 19 has been one of resilience…

Introduction No matter how much we yearn to recover our lost youth or the health that went along with it, every day brings us closer to death, the ultimate irritating limit. As Roman emperor Marcus Aurelius said, “do not act as if you were going to live ten thousand years. …

Angel investing is all about spotting potential in teams and companies. If you had invested $10,000 in Facebook’s seed round back in 2004, that money would be worth over $250 million today. The same goes for many other companies, where a seed investment would have made a 100x+ return. You…

You have probably heard time and time again to “diversify your portfolio” — this is to minimize overall risk and not put all your eggs in one basket. However, investing in early-stage startups, especially in healthcare, requires a slightly different approach. Venture capital differs from many other forms of investing…

Throughout history, there is a pattern that emerges over and over again: capital drives change. Wherever money is injected, innovation often follows. You hold a great amount of power as an investor because of this — you have the ability to influence where the money is directed, which means where…

EnClear Therapies is developing device-based systems to reduce or stop the progression of neurodegenerative diseases by eliminating the toxic proteins known to drive the underlying pathology of disease. EnClear’s initial focus is on ALS (Amyotrophic Lateral Sclerosis) and related disease groups such as PSP (Progressive Supranuclear palsy). ALS, also known…

The desire to prolong life existed for centuries from finding the holy grail to controversial start-ups such as Ambrosia focusing on teen blood transfusions. No one has been quite able to crack the code to immortality, however, a rising biotech start-up is taking a huge step forward in this space…